vs
Side-by-side financial comparison of Global Business Travel Group, Inc. (GBTG) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Global Business Travel Group, Inc. is the larger business by last-quarter revenue ($792.0M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Global Business Travel Group, Inc. runs the higher net margin — 10.5% vs 6.8%, a 3.7% gap on every dollar of revenue. On growth, Global Business Travel Group, Inc. posted the faster year-over-year revenue change (34.0% vs -1.7%). Over the past eight quarters, Global Business Travel Group, Inc.'s revenue compounded faster (13.9% CAGR vs -0.1%).
A travel management company (TMC) is a travel agency which manages organizations' corporate or business travel programs. Such companies will often provide an end-user online booking tool, mobile application, program management, and consulting teams, executive travel services, meetings and events support, reporting functionality, duty of care, and more. Non-Profit travel management companies also provide services to manage complex visa requirements, pre-trip medical needs, remote area travel, ...
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GBTG vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $792.0M | $493.8M |
| Net Profit | $83.0M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 3.7% | 9.9% |
| Net Margin | 10.5% | 6.8% |
| Revenue YoY | 34.0% | -1.7% |
| Net Profit YoY | 692.9% | 10.5% |
| EPS (diluted) | $0.16 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $792.0M | $493.8M | ||
| Q3 25 | $674.0M | $492.9M | ||
| Q2 25 | $631.0M | $468.8M | ||
| Q1 25 | $621.0M | $458.4M | ||
| Q4 24 | $591.0M | $502.4M | ||
| Q3 24 | $597.0M | $511.2M | ||
| Q2 24 | $625.0M | $504.3M | ||
| Q1 24 | $610.0M | $495.1M |
| Q4 25 | $83.0M | $33.7M | ||
| Q3 25 | $-62.0M | $71.7M | ||
| Q2 25 | $15.0M | $39.3M | ||
| Q1 25 | $75.0M | $20.7M | ||
| Q4 24 | $-14.0M | $30.5M | ||
| Q3 24 | $-128.0M | $19.4M | ||
| Q2 24 | $27.0M | $-153.0M | ||
| Q1 24 | $-19.0M | $4.0M |
| Q4 25 | 3.7% | 9.9% | ||
| Q3 25 | 1.8% | 13.8% | ||
| Q2 25 | 5.4% | 12.8% | ||
| Q1 25 | 8.9% | 7.0% | ||
| Q4 24 | 5.1% | 7.8% | ||
| Q3 24 | 4.5% | 6.6% | ||
| Q2 24 | 6.7% | -31.3% | ||
| Q1 24 | 2.6% | 3.2% |
| Q4 25 | 10.5% | 6.8% | ||
| Q3 25 | -9.2% | 14.5% | ||
| Q2 25 | 2.4% | 8.4% | ||
| Q1 25 | 12.1% | 4.5% | ||
| Q4 24 | -2.4% | 6.1% | ||
| Q3 24 | -21.4% | 3.8% | ||
| Q2 24 | 4.3% | -30.3% | ||
| Q1 24 | -3.1% | 0.8% |
| Q4 25 | $0.16 | $0.40 | ||
| Q3 25 | $-0.13 | $0.84 | ||
| Q2 25 | $0.03 | $0.46 | ||
| Q1 25 | $0.16 | $0.24 | ||
| Q4 24 | $-0.04 | $0.37 | ||
| Q3 24 | $-0.28 | $0.23 | ||
| Q2 24 | $0.06 | $-1.84 | ||
| Q1 24 | $-0.04 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $434.0M | $375.2M |
| Total DebtLower is stronger | $1.4B | $570.5M |
| Stockholders' EquityBook value | $1.6B | $865.9M |
| Total Assets | $4.9B | $2.2B |
| Debt / EquityLower = less leverage | 0.88× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $434.0M | $375.2M | ||
| Q3 25 | $427.0M | $340.1M | ||
| Q2 25 | $601.0M | $224.7M | ||
| Q1 25 | $552.0M | $99.0M | ||
| Q4 24 | $536.0M | $229.9M | ||
| Q3 24 | $524.0M | $103.8M | ||
| Q2 24 | $515.0M | $19.4M | ||
| Q1 24 | $475.0M | $8.0M |
| Q4 25 | $1.4B | $570.5M | ||
| Q3 25 | $1.4B | $577.2M | ||
| Q2 25 | $1.4B | $583.9M | ||
| Q1 25 | $1.4B | $590.5M | ||
| Q4 24 | $1.4B | $597.1M | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.6B | $865.9M | ||
| Q3 25 | $1.5B | $890.7M | ||
| Q2 25 | $1.2B | $833.8M | ||
| Q1 25 | $1.1B | $789.2M | ||
| Q4 24 | $1.1B | $764.9M | ||
| Q3 24 | $1.1B | $732.5M | ||
| Q2 24 | $1.2B | $706.5M | ||
| Q1 24 | $1.2B | $856.2M |
| Q4 25 | $4.9B | $2.2B | ||
| Q3 25 | $4.8B | $2.2B | ||
| Q2 25 | $3.9B | $2.1B | ||
| Q1 25 | $3.8B | $2.0B | ||
| Q4 24 | $3.6B | $2.2B | ||
| Q3 24 | $3.8B | $2.1B | ||
| Q2 24 | $3.8B | $2.0B | ||
| Q1 24 | $3.8B | $2.2B |
| Q4 25 | 0.88× | 0.66× | ||
| Q3 25 | 0.91× | 0.65× | ||
| Q2 25 | 1.15× | 0.70× | ||
| Q1 25 | 1.23× | 0.75× | ||
| Q4 24 | 1.32× | 0.78× | ||
| Q3 24 | 1.26× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $114.1M |
| Free Cash FlowOCF − Capex | $13.0M | — |
| FCF MarginFCF / Revenue | 1.6% | — |
| Capex IntensityCapex / Revenue | 4.9% | — |
| Cash ConversionOCF / Net Profit | 0.63× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $104.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $114.1M | ||
| Q3 25 | $71.0M | $137.3M | ||
| Q2 25 | $57.0M | $137.2M | ||
| Q1 25 | $53.0M | $-117.5M | ||
| Q4 24 | $65.0M | $133.0M | ||
| Q3 24 | $85.0M | $91.8M | ||
| Q2 24 | $73.0M | $107.0M | ||
| Q1 24 | $49.0M | $-125.2M |
| Q4 25 | $13.0M | — | ||
| Q3 25 | $38.0M | — | ||
| Q2 25 | $27.0M | — | ||
| Q1 25 | $26.0M | — | ||
| Q4 24 | $33.0M | — | ||
| Q3 24 | $59.0M | — | ||
| Q2 24 | $49.0M | — | ||
| Q1 24 | $24.0M | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 9.9% | — | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | 3.9% | — |
| Q4 25 | 4.9% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 3.8% | — | ||
| Q1 24 | 4.1% | — |
| Q4 25 | 0.63× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 3.80× | 3.49× | ||
| Q1 25 | 0.71× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GBTG
| Travel | $620.0M | 78% |
| Other | $172.0M | 22% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
